article thumbnail

Biofourmis announces major agreements with top pharmaceutical companies

Digital Health Global

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

article thumbnail

The Committee to Restore Nymox Shareholder Value Sends Letter to Nymox Pharmaceutical Shareholders and Issues Proxy Materials for Upcoming Special Meeting

Digital Health Global

Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. & The Committee to Restore Nymox Shareholder Value, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biggest trends and most likely strategic buyers expected to shape Digital Health M&A in 2024

Lloyd Price

Exec Summary: Digital health M&A activity is expected to remain strong in the next 12 months, but valuations are likely to remain under pressure. Digital health companies that can help providers and payers achieve their value-based care goals are likely to be attractive acquisition targets.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.

article thumbnail

Redi Health Lands $14 Million Investment to Continue Improving Patient Health Outcomes by Connecting Pharma, Providers, and Patients in One Platform

Healthcare IT Today

Redi Health will use the financing to foster innovation, develop and launch new products, expand its unique network, and accelerate overall growth. The funding underscores Redi Health’s success in reaching millions of patients across the country, solidifying its position as a leader in the digital health space.

article thumbnail

Aptar Appoints Julie Xing to its Board of Directors

Digital Health Global

With over 20 years of experience in pharmaceutical, medtech, digital health, biotech and diagnosis, Julie’s leadership approach focuses on inspiring teams to deliver sustainable growth in challenging markets and healthcare environments. Mundipharma is a global pharmaceutical leader. Tanda, Aptar President and CEO.

article thumbnail

CurvaFix Closes $39 Million Series C Financing Round Led by MVM Partners and Announces CEO Transition

Digital Health Global

CEO Transition Foster is an experienced C-Suite executive with a broad background in the healthcare, medical device, and pharmaceutical industries. Sports Medicine Business for Smith and Nephew and also held leadership roles at Boston Scientific. “I Formerly he was V.P. More information can be found at www.mvm.com. About CurvaFix, Inc.